Xiaodong Zhu

机构：XinHua Hospital · ORCID：0000-0002-7989-6326

发表论文 217 篇 · 总被引 2073 次 · h-index 23

代表论文

• Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 29)
• LBA60 Phase III study of SHR-1701 versus placebo in combination with chemo as first-line (1L) therapy for HER2-negative gastric/gastroesophageal junction adenocarcinoma (G/GEJA) (2024 · Annals of Oncology · 被引 14)
• First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study (2025 · Signal Transduction and Targeted Therapy · 被引 8)
• LBA19 SHR-A1811 versus pyrotinib plus capecitabine in human epidermal growth factor receptor 2-positive (HER2+) advanced/metastatic breast cancer (BC): A multicenter, open-label, randomized, phase III study (HORIZON-Breast01) (2025 · Annals of Oncology · 被引 7)
• The non-suicidal self-injury behaviour and its influencing factors in adolescents (2026 · BMC Pediatrics · 被引 1)
• Does hypoxemia aggravate sepsis-associated acute kidney injury? Integrated clinical and experimental evidence (2025 · Intensive Care Medicine Experimental · 被引 1)